CAREY STEPHEN P. 4

What Happened

• Stephen P. Carey, Senior Vice President & Chief Financial Officer of ANI Pharmaceuticals, exercised 3,313 stock options at $49.51 per share (total cost $164,027) on July 2, 2026 and sold the 3,313 shares the same day at $86.00 per share for $284,918. The Form 4 also reports the derivative exercise as a disposition for reporting purposes.

Key Details

• Transaction date: July 2, 2026
• Exercise: 3,313 shares at $49.51 — total exercise cost $164,027 (transaction code M)
• Sale: 3,313 shares at $86.00 — total proceeds $284,918 (transaction code S)
• Shares owned after transaction: Not disclosed in the provided Form 4 excerpt
• Filing: Form 4 filed July 6, 2026 (within the normal reporting window given July 4 holiday/weekend)
• Notable footnotes:
  • F1: Transactions were effected under a Rule 10b5-1 trading plan adopted March 6, 2026.
  • F2: The underlying options vested 25% on each of March 31, 2018, 2019, 2020 and 2021.

Context

• This was an option exercise followed by an immediate sale (commonly a cashless exercise), executed under a pre-established 10b5-1 plan — a routine way insiders can sell shares without indicating a short-term view. The filing is informational and does not, by itself, indicate the insider’s motivation.